Cox-regression analysis of predictors for anaemia among women of reproductive-age on ART in public hospitals, South West Ethiopia, 2020
| Variables | Anaemia | Cox-regression analysis | ||
| No N (%) | Yes N (%) | CHR (95% CI) | AHR (95% CI) | |
| Age of participant | ||||
| ≤35 | 98 (60.1) | 65 (39.9) | 1.00† | 1.00† |
| >35 | 69 (33.3) | 138 (66.7) | 1.84 (1.37 to 2.48)* | 0.98(0.70 to 1.36) |
| Residence | ||||
| Urban | 127 (54.3) | 107 (45.7) | 1.00† | 1.00† |
| Rural | 40 (29.4) | 96 (70.6) | 1.71 (1.30 to 2.26)* | 1.08(0.79 to 1.47) |
| Educational status | ||||
| Uneducated | 50 (36.5) | 87 (63.5) | 1.32 (1.00 to 1.75)* | 0.98(0.72 to 1.33) |
| Educated | 117 (50.2) | 116 (49.8) | 1.00† | 1.00† |
| Occupational status | ||||
| Non-employed | 91 (37.4) | 152 (62.6) | 1.75 (1.28 to 2.41)* | 1.47 (1.05 to 2.04)* |
| Employed | 76 (59.8) | 51 (40.2) | 1.00† | 1.00† |
| Baseline CD4 count | ||||
| <200 | 69 (39.0) | 108 (61.0) | 2.27 (1.18 to 4.34)* | 0.83(.41 to 1.66) |
| 200–349 | 42 (39.3) | 65 (60.7) | 2.08 (1.07 to 4.07)* | 0.76(.37 to 1.55) |
| 350–499 | 35 (63.6) | 20 (36.4) | 1.12(.53 to 2.39) | 0.78(.36 to 1.69) |
| ≥500 | 21 (67.7) | 10 (32.3) | 1.00† | 1.00† |
| Viral load count | ||||
| ≤1000 | 151 (51.9) | 140 (48.1) | 1.00† | 1.00† |
| >1000 | 16 (20.3) | 63 (79.7) | 1.88 (1.39 to 2.54)* | 1.14(.81 to 1.62) |
| Baseline WHO clinical stage | ||||
| I | 45 (73.8) | 16 (26.2) | 1.00† | 1.00† |
| II | 68 (59.6) | 46 (40.4) | 1.42 (0.80 to 2.50) | 1.54 (0.86 to 2.74) |
| III | 34 (32.1) | 72 (67.9) | 3.08 (1.79 to 5.31)* | 2.48 (1.39 to 4.42)* |
| IV | 20 (22.5) | 69 (77.5) | 3.55 (2.06 to 6.12)* | 2.49 (1.40 to 4.43)* |
| OIs at baseline | ||||
| Yes | 45 (22.6) | 154 (77.4) | 3.38 (2.44 to 4.68)* | 2.99 (2.12 to 4.23)* |
| No | 122 (71.3) | 49 (28.7) | 1.00† | 1.00† |
| Duration of ART (in years) | ||||
| ≤6 | 92 (73.6) | 33 (26.4) | 1.00† | 1.00† |
| >6 | 75 (30.6) | 170 (69.4) | 3.07 (2.11 to 4.47)* | 1.63 (1.04 to 2.55)* |
*Adjusted for all significant variables p<0.05.
†Reference category.
AHR, adjusted HR; ART, antiretroviral therapy; CD4, cluster of differentiation 4; CHR, crude HR; OIs, opportunistic infections.